Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis?

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 6, 1997, Pages 582-590

  Johanshn, J S ^a   Moller S ^b   Price, P A ^b   Bendtsen, F ^b   Jungh, J ^b   Garbarsch, C ^b   Henriksen, J H ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

Alcoholic; Amino terminal propeptide; Biochemical markers; Cirrhosis; Human type III procollagen; Liver fibrosis

Indexed keywords

BIOLOGICAL MARKER; HEPARIN BINDING PROTEIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION;

EID: 0030785775     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709025104     Document Type: Article

References (30)

1. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-35.
2. Bissell DM, Friedman SL, Maher JJ, Roll FJ. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990;11:488-98.
3. Iredale JP. Matrix turnover in fibrogenesis (review). Hepatogastroenterology 1996;43:56-71.
4. Johanscn JS, Jensen HS, Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
5. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
6. Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996;271:19415-20.
7. Coulson AFW. A proposed structure for 'Family 18' chitinases. A possible function for narbonin. FEBS Letters 1994;354:41-4.
8. Rejman JJ, Hurley WL. Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun 1988;150:329-34.
9. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501-12.
10. Nyirkos P, Golds EE. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 1990;268:265-8.
11. Shackelton LM, Mann DM, Millis AJT. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995;270:13076-83.
12. Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-26.
13. Johansen JS, Hansen M, Stoltenberg M, Florescu A, Hørslev-Petersen K, Price PA. Docs serum YKL-40 reflect inflammatory and disease activity in rheumatoid arthritis? XIIIth European Congress of Rheumatology (EULAR), Amslerdam, The Netherlands, June 1995, Abstract D158B.
14. Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996;35:553-9.
15. Johansen JS, Stoltenberg M, Hansen M, Hansen TM, Price PA, Gøtzsche PC. Serum YKL-40 reflects disease relapse after withdrawal of SAARD in patients with rheumatoid arthritis. ACR 60th National Scientific Meeting, Orlando, USA, October 1996, Abstract 768.
16. Volck B, Johansen JS, Stoltenberg M, Østergaard M, Price PA, Lorenzen I. Serum YKL-40 reflects pharmacological induced reduction of synovial inflammation of the knee joint in patients with rheumatoid arthritis. ACR 60th National Scientific Meeting, Orlando, USA, October 1996, Abstract 769.
17. Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995;31A:1437-42.
18. Gluud C, Copenhagen study group for liver diseases. Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation. Metabolism 1987;36:373-8.
19. Junge J, Horn T, Christoffersen P. The occurrence and significance of fibronectin in livers from chronic alcoholics. APMIS 1988;96:56-61.
20. Henriksen JH. Variability of hydrostatic hepatic vein and ascitic fluid pressure and of plasma and ascitic fluid colloid osmotic pressure in patients with liver cirrhosis. Scand J Clin Lab Invest 1980;40:515-22.
21. Henriksen JH, Ring-Larsen H, Kanstrup I-L, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis: evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984;25:1034-43.
22. 99mTc-dicthyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987;4:66-70.
23. Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection and the influence of uneven distribution. Acta Physiol Scand 1963;58:162-9.
24. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34: 715-8.
25. Mathew J, Geerts A, Burt AD. Pathobiology of hepatic stellate cells (review). Hepatogastroenterology 1996;43:72-91.
26. Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, et al. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver 1987;7:339-46.
27. Ramadori G, Zöhrens G, Manns M, Rieder H, Dienes HP, Hess G, et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991;21:323-30.
28. Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 1994;40:1641-51.
29. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399-403.
30. Beeuwkes R, Ichikawa I, Brenner MB. The renal circulation. In: Brenner BM, Rector FC, editors. The kidney. Vol. 1. Philadelphia: W. B. Saunders Company, 1981:249-88.